Hematology/Oncology Education and CME

Select a Specialty

Breast Cancer Awareness
VIDEO

Breast Cancer Awareness

December 8, 2017
Credit Type(s): | Credit: 0

Adam M. Brufsky, MD, PhD, serves as both professor of medicine and associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh…

go to activity »
Immune Checkpoint Inhibitors in Advanced Melanoma: What You May Have Missed in Madrid
CME

Immune Checkpoint Inhibitors in Advanced Melanoma: What You May Have Missed in Madrid

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 11/30/2018
Credit Type(s): CME | Credit: 1

The incidence of melanoma in the United States continues to rise as demonstrated by the Surveillance, Epidemiology and End Results (SEER) data, which shows a 60%…

go to activity »
Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago
CMEABIM MOC

Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

There is no commercial support for this activity.

Expiration Date: 10/25/2018
Credit Type(s): CME / ABIM/MOC | Credit: 0.25

This “Ace the Case” study will utilize a case study to discuss the treatment of 48-year-old female who was diagnosed with polycythemia vera (PV) 7 years ago. Accurately…

go to activity »
Expert Perspectives: The Latest Evidence Regarding Immune Checkpoint Inhibitors for Advanced Bladder Cancer
CME

Expert Perspectives: The Latest Evidence Regarding Immune Checkpoint Inhibitors for Advanced Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 11/15/2018
Credit Type(s): CME | Credit: 1

In 2016, the first immune checkpoint inhibitor was approved by the US Food and Drug Administration (FDA) for the second-line treatment of patients with locally advanced…

go to activity »
Meeting Rewind Video Highlights from HemOnc Today Melanoma
VIDEO

Meeting Rewind Video Highlights from HemOnc Today Melanoma

August 31, 2017
Credit Type(s): | Credit: 0

Select video presentations from HemOnc Today Melanoma include topics such as melanoma pathways and targeted therapeutics….

go to activity »
Patient counseling lessons from three sarcoma experts

Patient counseling lessons from three sarcoma experts

May 1, 2017
Credit Type(s): | Credit: 0

Read what three clinicians have to say about the current state of sarcoma treatment options….

go to activity »
Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks
CMEABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

Expiration Date: 11/14/2018
Credit Type(s): CME / ABIM/CME | Credit: 0.25

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent, painless hematuria for the past 4 weeks. Accurately…

go to activity »
Liver Cancer Awareness
VIDEO

Liver Cancer Awareness

November 6, 2017
Credit Type(s): | Credit: 0

John P. Roberts, MD, professor of surgery and Chief of the University of California – San Francisco Transplant Service, discusses topics such as the epidemiology of…

go to activity »
Expert Insights: Genomic Testing for the Extended Endocrine Therapy Dilemma in ER+ Breast Cancer
VIDEO

Expert Insights: Genomic Testing for the Extended Endocrine Therapy Dilemma in ER+ Breast Cancer

This activity is produced by SLACK Incorporated and sponsored by Biotheranostics. Participating physicians are paid consultants of Biotheranostics.

October 24, 2017
Credit Type(s): | Credit: 0

Extending the duration of endocrine therapy beyond 5 years in women with early-stage, estrogen receptor–positive (ER+) breast cancer has been shown in several clinical…

go to activity »
Lymphoma Central: Seeking Cures, Finding Hope

Lymphoma Central: Seeking Cures, Finding Hope

October 11, 2017
Credit Type(s): | Credit: 0

Lymphoma Central is here, your hub for treatment breakthroughs, clinical trial news and expert analysis….

go to activity »
Expert Update: What's New in Essential Thrombocythemia
CME

Expert Update: What's New in Essential Thrombocythemia

This activity is supported by an educational grant from Incyte Corporation.

Expiration Date: 8/22/2018
Credit Type(s): CME | Credit: 0.5

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms (MPNs) to enhance clinical outcomes and patient…

go to activity »
Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies
CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 4/27/2018
Credit Type(s): CME | Credit: 1

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed in 2017. The early detection of melanoma is…

go to activity »